Protecting fertility in young cancer patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to enhance fertility preservation and long-term care for children, adolescents, and young adults undergoing cancer treatments or stem cell transplantation. It focuses on identifying factors that predict fertility issues post-treatment, addressing the concerns of patients and their families, and improving clinical practices related to fertility preservation. By creating a comprehensive database, the study seeks to document critical risk factors and improve the quality of care for this vulnerable population.

Why it matters

Who can join: the full rules

Children, adolescents, young adults with a diagnosis of cancer before the age of 21 years

or

Children, adolescents, young adults undergoing SCT for a malignant or non-malignant condition before the age of 21 years

treated at the Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Germany.

Where it's running

• Universitätsklinikum Ulm, Klinik für Kinder- und Jugendmedizin, Sektion Pädiatrische Endokrinologie und Diabetologie
  Ulm, Baden-Wurttemberg, Germany Recruiting

Study contacts

• Principal investigator: Christian Denzer, Prof. Dr. — Ulm University Medical Centre - Division of Paediatric Endocrinology and Diabetes
• Study coordinator: Christian Denzer, Prof. Dr.
• Email: christian.denzer@uniklinik-ulm.de
• Phone: +49 731 500 57056

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Personalised nutrition tool for teens undergoing cancer treatment

  A smartphone app called MybYte tests a tailored nutrition plan for teenagers aged 12–18 who are receiving cancer treatment to see if it is helpful and easy to use.

  Recruiting KU Leuven · Leuven, Vlaams Brabant · NCT07865117

• Gemcitabine, Docetaxel, Melphalan, and Carboplatin with a Second Transplant in Young Patients with Relapsed Germ Cell Tumors

  This study tests whether a tandem autologous stem cell transplant with GemDMC, followed by CE, can help children and teens with relapsed or refractory germ cell tumors.

  Recruiting M.D. Anderson Cancer Center · Houston, Texas · NCT07662018

• Electronic mindfulness-based music therapy for patients receiving stem cell transplantation

  This trial tests an eHealth mindfulness-based music therapy to see if it improves quality of life and reduces symptoms for adults undergoing stem cell transplantation.

  Recruiting University of Miami · Miami, Florida · NCT07469592

• Reproductive outlook for women trying to conceive after medical or surgical treatment for endometriosis

  This study will try to see whether women treated medically or surgically for endometriosis are more likely to need medically assisted reproduction (PMA) and how their conception and pregnancy outcomes compare.

  Recruiting Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Milan, MI, Italia · NCT07437742

• Plan A male contraceptive system to block and restore sperm flow

  This test checks whether the Plan A male contraceptive system can block sperm by occluding the vas deferens and later be reversed in men seeking vasectomy-like contraception.

  Recruiting at 2 sites Phase 2 Next Life Sciences · Maribyrnong, Victoria and 2 other locations · NCT07361120

• Venetoclax added to reduced-intensity conditioning for combined stem cell and kidney transplant

  This trial tests whether adding venetoclax to a reduced-intensity conditioning regimen is safe for adults with blood cancers who are receiving a combined stem cell and kidney transplant from a matched or partially matched donor.

  Recruiting Early Phase 1 Massachusetts General Hospital · Boston, Massachusetts · NCT07358195

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.